Three Questions
Three Questions: Prof. Stephen Roach on Who Wins in the U.S.-China Trade War
Yale’s Stephen Roach argues that the two countries are actually in a “codependent” relationship—meaning each needs the other to offset imbalances in their system.
Three Questions: Prof. James Baron on Amazon’s New Minimum Wage
We asked Prof. James Baron, an expert in human resources and labor markets, what Amazon’s $15 minimum wage would mean for workers there and at other companies.
Three Questions: Is This the End of Sears?
After decades of decline, Sears filed for bankruptcy in October. Yale Insights asked bankruptcy expert Stanley Garstka what would remain of the once-dominant retailer and its heritage at the end of the process.
Three Questions: Prof. Jason Abaluck on Short-Term Health Insurance
We asked Yale SOM health economist Jason Abaluck how the expansion of low-cost, short-term insurance could affect consumers and the insurance markets.
Three Questions: Prof. David Bach on Doing Business with Saudi Arabia
Professor David Bach answers questions about how businesses should weigh the risks and reputational costs in how they respond to the disappearance of Saudi Arabian journalist Jamal Khashoggi.
Three Questions: Prof. Paul Bracken on Europe after Brexit
Yale SOM’s Paul Bracken, an expert in political science and strategy, says that Brexit is just one of the political and economic disruptions reshaping Europe.
Three Questions: Prof. Barbara Biasi on Teacher Pay
We asked Barbara Biasi, a labor economist with a focus on education, about this year’s teachers' strikes and the wider implications of how we compensate teachers.
Three Questions: Prof. Jacob Thomas on Tesla’s Bid to Go Private
We asked Yale SOM’s Jacob Thomas, an expert on stock prices and company valuation, about the prospects for Elon Musk’s plan.
Three Questions: Prof. Peter K. Schott on Tariffs and Trade Wars
President Trump has imposed a series of tariffs, raising tensions with allies and prompting other countries to respond in kind. We asked Yale SOM’s Peter K. Schott, who studies how firms and workers respond to globalization, to assess the current climate.
Three Questions: Dr. Greg Licholai on Biotech After Theranos
We asked Dr. Greg Licholai, a lecturer at Yale SOM and and a biotech entrepreneur, what other healthcare startups can learn from the Theranos debacle.